Biobizkaia
Centre de recherche
Instituto Universitario de Oncologia del Principado de Asturias
Oviedo, EspañaPublications en collaboration avec des chercheurs de Instituto Universitario de Oncologia del Principado de Asturias (11)
2024
-
The lipopolysaccharide-TLR4 axis regulates hepatic glutaminase 1 expression promoting liver ammonia build-up as steatotic liver disease progresses to steatohepatitis
Metabolism: Clinical and Experimental, Vol. 158
2023
-
Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients
Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 205-215
-
The outcome of boosting mitochondrial activity in alcohol-associated liver disease is organ-dependent
Hepatology (Baltimore, Md.), Vol. 78, Núm. 3, pp. 878-895
2022
-
Characteristics of Whale Müller Glia in Primary and Immortalized Cultures
Frontiers in Neuroscience, Vol. 16
-
Prognostic implications of comorbidity patterns in critically ill COVID-19 patients: A multicenter, observational study
The Lancet Regional Health - Europe, Vol. 18
2020
-
Circulating tumor cells for comprehensive and multiregional non-invasive genetic characterization of multiple myeloma
Leukemia, Vol. 34, Núm. 11, pp. 3007-3018
2018
-
MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosis
Cell Death and Disease, Vol. 9, Núm. 10
2017
-
Epigenetic modulators of thyroid cancer
Endocrinologia, Diabetes y Nutricion
2016
2013
-
La notificación directa por los pacientes de reacciones adversas a medicamentos en España
Farmacia Hospitalaria, Vol. 37, Núm. 1, pp. 65-71